drugset / Trial / NCT07374211

Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression

NCT07374211

Not yet recruiting 242 enrolled Chinese PLA General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

This project employs a prospective, randomized, controlled, blinded, dual-center study design to investigate the effects of intraoperative esketamine on perioperative anxiety and depression symptoms in patients with severe depression undergoing breast cancer surgery.

Timeline

Start
2026-01-18
Primary completion
2026-01-18
Completion
2027-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.3 mg/kg Intravenous